Senti Biosciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $333 | $333 |
Gross Profit | -1,467 | -1,461 | -1,141 | |
EBITDA | -13,438 | -11,889 | -14,840 | -16,953 |
EBIT | -14,902 | -13,356 | -16,301 | -18,427 |
Net Income | -28,866 | -11,203 | -12,111 | -18,716 |
Net Change In Cash | 0 | 0 | 333 | 333 |
Free Cash Flow | -7,866 | -8,345 | -11,697 | -7,041 |
Cash | 10,479 | 15,860 | 23,723 | 35,926 |
Basic Shares | 4,577 | 4,572 | 4,570 | 44,658 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $2,561 | $4,286 | $2,291 | $394 |
Gross Profit | -2,683 | 4,286 | -719 | -15,562 |
EBITDA | -61,336 | -66,709 | -39,677 | -22,709 |
EBIT | -66,765 | -70,629 | -42,687 | -24,694 |
Net Income | -92,919 | -45,791 | -55,319 | -19,862 |
Net Change In Cash | 2,561 | 4,286 | 2,291 | 394 |
Cost of Revenue | 1,696 | |||
Free Cash Flow | -64,433 | -76,270 | -40,178 | -25,334 |
Cash | 35,926 | 57,621 | 56,034 | 30,537 |
Basic Shares | 4,437 | 2,611 | 4,365 | 4,365 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$6.30 |
2024-06-30 | -$2.45 |
2024-03-31 | -$0.26 |
2023-12-31 | -$0.41 |
